4
Changes in Ownership
GALECTIN THERAPEUTICS INC Filed Acc 0001133416-23-000002
President and CEO acquired 15,487 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LEWIS JOEL · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-30 | Grant or award : show line 1 in the form | +15,487 | $1.13 | $17,500 | 698,867 | D |
Loading xslF345X03/form4.xml…